A committee of subject matter experts established by the Comptroller General of Drugs of India (DCGI) to review COVID-19 vaccine proposals, recommended an “interim efficacy analysis for Covaxin.” The vaccine was developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR). The expert committee asked a …
Read More »Serum Institute denies claim of side effects, says Covishield ‘safe and immunogenic
After a Chennai man claimed he suffered neurological and psychological side effects from receiving an injection of the Covid-19 Covishield vaccine during the human trial being conducted by the Serum Institute of India (SII), the company based in Pune said there was no correlation between the two. In a post …
Read More »Doctors, MBBS students among 30 million people who will receive the Covid-19 vaccine first, Aadhaar is not required
As Bharat Biotech aims to launch its vaccine, Covaxin, in February, which could be the first vaccine available in India, the Center is finalizing the procedure for administering the vaccine, including identifying the priority groups to target. they will administer the vaccine first and at no cost. . The group …
Read More »Russia signs an agreement with Dr. Reddy’s for the Sputnik V trial in India, to supply 100 million doses
The Russian Fund for Direct Investment has signed an agreement with Dr. Reddy’s Laboratories to conduct a clinical trial and distribution of Sputnik V in India. Under the agreement, Russia’s sovereign wealth fund will supply 100 million doses of Russia’s COVID-19 vaccine to the Indian pharmaceutical company. Both the trials …
Read More »